Ignite Creation Date:
2024-05-06 @ 6:01 PM
Last Modification Date:
2024-10-26 @ 2:39 PM
Study NCT ID:
NCT05511077
Status:
COMPLETED
Last Update Posted:
2023-02-21
First Post:
2022-08-19
Brief Title:
Biomarkers of Oat Product Intake The BiOAT Marker Study
Sponsor:
Chalmers University of Technology
Organization:
Chalmers University of Technology
Study Overview
Official Title:
Biomarkers of Oat Product Intake The BiOAT Marker Study
Status:
COMPLETED
Status Verified Date:
2023-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The aim of this project is to evaluate avenanthramides and avenacosides and their metabolites as specific biomarkers of oat product intake in humans Biomarkers will be evaluated after i a single dose through a single meal based on a solid and a liquid oat-based product pharmacokinetic study ii week-long consumption at three different intake levels dose-response The study will be carried out as a two-way cross-over design with two different oat products liquid or solid where each product is provided 3 times per day during 5 days per product A wash-out period of 8 days where participants consume their habitual diet is implemented The first day of study meal intervention includes postprandial measurements during 8 hours
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None